🔎 Trials Near Me

Akèy › Leksemi biphenotipik egi › Tennessee › Memphis

Etid klinik pou Leksemi biphenotipik egi nan Memphis, TN

7 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Laj 1 a 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Ap rekriteFaz 4
  • St. Jude Children's Research Hospital, Memphis
Laj 1 a 18 · Tout sèks · Mizajou Jul 14, 2026 · NCT06289673

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Ap rekriteFaz 1/2
  • Baptist Clinical Research Institute, Memphis
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Leksemi biphenotipik egi nan lòt vil

Lòt etid nan Memphis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.